As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: January 5, 2018
by Sheila Jacobs for Neurology Advisor:
Increased triglyceride levels at midlife are predictive of the presence of β-amyloid (Aβ) and tau pathologies 20 years later in cognitively healthy individuals, according to the results of a recent longitudinal cohort study published in Neurology.
The current study sought to assess the impact of midlife lipid levels on Alzheimer disease (AD) brain pathology 20 years later in cognitively normal elderly individuals. A total of 318 participants with data available on fasting lipid levels at midlife (mean age, 54 years) were enrolled in the analysis. The presence of Aβ and tau pathologies 20 years later (mean age, 73 years) was identified by quantifying AD biomarkers in cerebrospinal fluid (CSF). In a subpopulation of 134 individuals, brain Aβ was also measured via positron emission tomography (PET) scans.
CSF Aβ42 and Aβ PET revealed the presence of Aβ in approximately 20% of the cognitively healthy population. The CSF Aβ42/phosphorylated tau (p-tau) ratio demonstrated both Aβ and tau pathologies in 16% of the healthy individuals.
Higher levels of triglycerides in midlife were significantly associated with abnormal CSF Aβ42 (odds ratio [OR] 1.34; 95% CI, 1.03-1.75; P =.029) and with abnormal Aβ42/p-tau ratio (OR 1.46; 95% CI, 1.10-1.93; P =.009), after adjusting for age, sex, APOE ε4 status, education, and vascular risk factors. Triglycerides were also associated with abnormal Aβ PET scans in multivariable regression models (P =.013 and P =.025, based on the model evaluated), but the association was somewhat decreased in the fully adjusted model.
Depression is associated with accelerated brain aging, according to a new study by psychologists at the University of Sussex in England. While previous research has shown that individuals with depression or anxiety have a...
Alzheimer’s disease (AD) is a progressive brain disease and the 6th leading cause of death in the U.S. While symptoms of AD such as memory loss and impaired judgement are widely recognized, we know less...
Autoimmune diseases, such as multiple sclerosis and coeliac disease, may be linked to a heightened risk of dementia, indicates a large long term study published in the Journal of Epidemiology & Community Health March 1, 2017. Researchers...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.
